Independent medical laboratories to support clinical trials of phases I – IV

The GBA Group's independent medical laboratories support clinical trials of phases I – IV. From planning to completion, the broad spectrum of services covers all aspects of the laboratory part of clinical trials. The GBA Group has considerable experience and expertise in a variety of clinical indications, their diagnosis and therapy.

With our global network of partner laboratories in Europe, North America, South America and China, we provide laboratory services for clinical trials around the world. Dedicated and experienced project managers are assigned to each study ensuring a long-term consistency within a project.

From the beginning, the GBA Group is aware of the importance of a continuous and timely information of all responsible persons involved in a clinical trial - and we are convinced that communication is one of our strengths.

A wide range of bioanalytical methodologies

The GBA Group provides a wide range of bioanalytical methodologies supporting all phases of the drug development process. Our highly qualified staff is experienced in the following bioanalytical areas.

A comprehensive clinical laboratory testing program

The GBA Group offers a comprehensive clinical laboratory testing programme. Whenever possible, the methods and procedures applied are those recommended by international scientific societies, e.g. IFCC, ECAT, or methods traceable to approved reference material.

Furthermore, the GBA Group has expertise in the development, evaluation and reference interval establishment of new analytical methods. 

Analyses are performed in a timely and accurate manner. Measurements of routine and safety parameters, including reporting of test results, are usually completed on the day of specimen receipt, six days a week.